Skip to main content

View full-text article in PMC

. 2016 May 27;11(5):e0155132. doi: 10.1371/journal.pone.0155132

Table 1. Correlations between subtype and clinicopathological parameters in 48 PMC patients^$.

Parameters		PMC(N = 48)		Significance
Parameters		PPMC-A(N = 38)	PPMC-B(N = 10)	Significance
Age (years, mean±SD)		50.58±13.29	57.80±12.37	F = 2.400, p = 0.128
Tumor size (mm, mean±SD)		30.13±22.51	29.80±13.25	F = 0.002, p = 0.965
Number of positive LN (mean±SD)		0.87±2.76	0.10±0.32	F = 0.759, p = 0.388
LN status	Negative	30	9	χ² = 0.635, p = 0.426
LN status	Positive	8	1	χ² = 0.635, p = 0.426
Stage	I	11	3	χ² = 0.850, p = 0.838
	II	24	7
	III	2	0
	IV	1	0
ER	Negative	5	2	χ² = 0.298, p = 0.585
ER	Positive	33	8	χ² = 0.298, p = 0.585
PR	Negative	9	4	χ² = 1.067, p = 0.302
PR	Positive	29	6	χ² = 1.067, p = 0.302
HER2	Negative	36	9	χ² = 0.303, p = 0.582
HER2	Positive	2	1	χ² = 0.303, p = 0.582
p53	Negative	26	9	χ² = 1.867, p = 0.172
p53	Positive	12	1	χ² = 1.867, p = 0.172

^$ PMC: pure mucinous breast carcinoma; PMC is subtyped into hypocellular PMC (PMC-A) and hypercellular PMC (PMC-B).